Detailed profile of cognitive dysfunction in children with aspartylglucosaminuria

被引:5
作者
Harjunen, Elina Leena [1 ]
Laine, Minna [1 ]
Tikkanen, Ritva [2 ]
Helenius, Paivi [1 ]
机构
[1] Helsinki Univ Hosp, Div Child Neurol, Helsinki, Finland
[2] Univ Giessen, Med Fac, Inst Biochem, Giessen, Germany
关键词
aspartylglucosaminuria; cognitive functions; disorder of glycoprotein degradation; intellectual disability; lysosomal storage disease; neuropsychology; MUTATION; GENE;
D O I
10.1002/jimd.12159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aspartylglucosaminuria (AGU) is a rare, recessively inherited lysosomal disease with relatively high prevalence in Finnish population. This progressive disease has a vast impact on patient's cognition and physical health, leading to intellectual disability and shorter life expectancy. Cognitive functions of 21 7- to 14-year-old children with AGU were studied cross-sectionally using Wechsler's Intelligence Scale for Children IV and the results were compared with a standardized Finnish sample. In addition to overall cognitive performance, abilities in discrete cognitive domains, including verbal comprehension, perceptual reasoning, working memory, and processing speed, were examined. The results showed that despite the very low overall level of cognitive performance, there were notable differences between individuals. All those children whose performance was closer to their own age level were 7 to 10 years old. Processing speed appeared more compromised, as compared with verbal comprehension. Furthermore, examining the subtest raw scores, there were no significant positive correlations between age and subtest scores, suggesting that the developmental level of AGU children could be rather stable throughout ages 7 to 14. This study gives insight to the severe nature of AGU disease. Since younger children performed better compared to their age norms than older children, the results raise a question whether the highest peak in cognitive functions is reached at an earlier age than previously thought.
引用
收藏
页码:318 / 325
页数:8
相关论文
共 25 条
  • [1] Neurocognitive profiles in Salla disease
    Alajoki, L
    Varho, T
    Posti, K
    Aula, P
    Korhonen, T
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2004, 46 (12) : 832 - 837
  • [2] FOLLOW-UP IN PATIENTS WITH ASPARTYLGLUCOSAMINURIA .1. THE COURSE OF INTELLECTUAL FUNCTIONS
    ARVIO, M
    [J]. ACTA PAEDIATRICA, 1993, 82 (05) : 469 - 471
  • [3] Aspartylglycosaminuria: a review
    Arvio, Maria
    Mononen, Ilkka
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11 : 1 - 10
  • [4] Progressive nature of aspartylglucosaminuria
    Arvio, P
    Arvio, M
    [J]. ACTA PAEDIATRICA, 2002, 91 (03) : 255 - 257
  • [5] Autio S, 1972, J Ment Defic Res, V1, P1
  • [6] Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder Aspartylglucosaminuria
    Banning, Antje
    Schiff, Manuel
    Tikkanen, Ritva
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (03): : 668 - 675
  • [7] Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria
    Banning, Antje
    Guelec, Christina
    Rouvinen, Juha
    Gray, Steven J.
    Tikkanen, Ritva
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [8] Bluma S, 1976, PORTAGE GUIDE EARLY
  • [9] Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis
    Borgwardt, L.
    Thuesen, A. M.
    Olsen, K. J.
    Fogh, J.
    Dali, C. I.
    Lund, A. M.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (06) : 1119 - 1127
  • [10] Cognitive and behaviour profiles of children with mucopolysaccharidosis Type II
    Crowe, Louise
    Yaplito-Lee, Joy
    Anderson, Vicki
    Peters, Heidi
    [J]. COGNITIVE NEUROPSYCHOLOGY, 2017, 34 (06) : 347 - 356